A detailed history of Arlington Partners LLC transactions in Haleon PLC stock. As of the latest transaction made, Arlington Partners LLC holds 508,886 shares of HLN stock, worth $4.88 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
508,886
Previous 223,194 128.0%
Holding current value
$4.88 Million
Previous $2.31 Million 97.23%
% of portfolio
1.76%
Previous 0.93%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

BUY
$8.72 - $10.35 $2.49 Million - $2.96 Million
285,692 Added 128.0%
508,886 $4.56 Million
Q2 2025

Jul 14, 2025

BUY
$9.27 - $11.41 $2.07 Million - $2.55 Million
223,194 New
223,194 $2.31 Million
Q2 2023

Jul 26, 2023

BUY
$8.04 - $9.0 $3,215 - $3,600
400 New
400 $3,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Arlington Partners LLC Portfolio

Follow Arlington Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.